Were A Little Worried About Virios Therapeutics Cash Burn Rate

VIRIDelisted Stock  USD 3.95  0.00  0.00%   
Under 55% of Virios Therapeutics' investor base is interested to short. The analysis of current outlook of investing in Virios Therapeutics Llc suggests that many traders are impartial regarding Virios Therapeutics' prospects. Virios Therapeutics' investing sentiment shows overall attitude of investors towards Virios Therapeutics Llc.
  
Even when a business is losing money, its possible for shareholders to make money if they buy a good business at the...

Read at finance.yahoo.com
Yahoo News
  

Virios Therapeutics Fundamental Analysis

We analyze Virios Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Virios Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Virios Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Net Asset

Net Asset Comparative Analysis

Virios Therapeutics is currently under evaluation in net asset category among its peers. Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.

Virios Therapeutics Llc Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Virios Therapeutics stock to make a market-neutral strategy. Peer analysis of Virios Therapeutics could also be used in its relative valuation, which is a method of valuing Virios Therapeutics by comparing valuation metrics with similar companies.

Peers

Virios Therapeutics Related Equities

CYTOAltamira Therapeutics   7.50   
0%
90.0%
IMMXImmix Biopharma   7.11   
0%
85.0%
PHIOPhio Pharmaceuticals   3.03   
0%
36.0%
RNAZTranscode Therapeutics   2.94   
0%
35.0%
ZURAZura Bio   1.67   
0%
20.0%
REVBRevelation Biosciences   1.33   
0%
15.0%
ICULMF Acquisition   1.57   
18.0%
0%
SONNSonnet Biotherapeutics   2.28   
27.0%
0%
ZVSAZyVersa Therapeutics   3.60   
43.0%
0%
CNSPCns Pharmaceuticals   8.33   
100.0%
0%
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Consideration for investing in Virios Stock

If you are still planning to invest in Virios Therapeutics Llc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Virios Therapeutics' history and understand the potential risks before investing.
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Insider Screener
Find insiders across different sectors to evaluate their impact on performance